CA
SBRA icon

Clearstead Advisors’s Sabra Healthcare REIT SBRA Stock Holding History

Clearstead Advisors’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.41K Buy
277
+212
+326% +$4.21K ﹤0.01% 2169
2026
Q1 		$1.25K Sell
65
-789
-92% -$15.5K ﹤0.01% 2003
2025
Q4 		$16.2K Sell
854
-59
-6% -$1.09K ﹤0.01% 1775
2025
Q3 		$17K Buy
913
+702
+333% +$13.1K ﹤0.01% 1717
2025
Q2 		$3.89K Buy
+211
New +$3.74K ﹤0.01% 2182
2025
Q1 		– Sell
-8
Closed -$139 – 2301
2024
Q4 		$139 Buy
+8
New +$146 ﹤0.01% 2041

Other funds holding SBRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIM
Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Clearstead Advisors's SBRA Position: Q2 2026 in Review

Clearstead Advisors increased its Sabra Healthcare REIT (SBRA) stake by 326% in Q2 2026, buying an estimated $4.21K and bringing the position to 277 shares worth $5.41K. The position accounts for ﹤0.01% of the portfolio, ranked #2169.

Clearstead Advisors first reported a position in SBRA in Q4 2024 and has held it in 6 quarters since. The position peaked at $17K in Q3 2025. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Clearstead Advisors held 277 shares of Sabra Healthcare REIT worth $5.41K as of Q2 2026.
  • Clearstead Advisors bought 212 Sabra Healthcare REIT shares in Q2 2026, an estimated $4.21K.
  • Sabra Healthcare REIT made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2169 holding.
  • Clearstead Advisors first reported a position in Sabra Healthcare REIT in Q4 2024 and has held it in 6 quarters since.
  • Clearstead Advisors's Sabra Healthcare REIT position peaked at $17K in Q3 2025.
  • 464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.